M. TERESA
CEDENA ROMERO

Profesora asociada de Ciencias de la Salud

Foto de M. TERESA

Foto de T.

T.
Bernal

Publicaciones en las que colabora con T. Bernal (6)

2022

Relevance of infections on the outcomes of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia treated with hypomethylating agents: a cohort study from the GESMD
Therapeutic Advances in Hematology, Vol. 13
Response to azacitidine in patients with chronic myelomonocytic leukemia according to overlap myelodysplastic/myeloproliferative neoplasms criteria
Leukemia Research, Vol. 116

2021

Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia
Leukemia, Vol. 35, Núm. 8, pp. 2358-2370

2018

The division of chronic myelomonocytic leukemia (CMML)-1 into CMML-0 and CMML-1 according to 2016 World Health Organization (WHO) classification has no impact in outcome in a large series of patients from the Spanish group of MDS
Leukemia Research

2016

Response to erythropoietic-stimulating agents in patients with chronic myelomonocytic leukemia
European Journal of Haematology, Vol. 97, Núm. 1, pp. 33-38

2014

Results of treatment with azacitidine in patients aged ≥ 75 years included in the Spanish Registry of Myelodysplastic Syndromes
Leukemia and Lymphoma, Vol. 55, Núm. 6, pp. 1300-1303